Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT02768038
NCT02768038WithdrawnNot Applicable

The Role of Intestinal Microbiome ih the Pathogenesis and Course of Chronic Inflammatory Bowel Diseases

Turku University Hospital1 site in 1 country120 target enrollmentStarted: May 1, 2016Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Withdrawn
Enrollment
120
Locations
1
Primary Endpoint
Change of microbiome in chronic inflammatory bowel disease
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

The aim is to examine the role of intestinal microbiota in the pathogenesis of chronic inflammatory bowel diseases (IBD)

Detailed Description

IBD patients to whom colonoscopy is performed will be recruited. Mucosal specimens from large intestine and terminal ileum will be collected as well as stool specimens. The microbiota will be analyzed at the microbiology laboratory and the results will be correlated with endoscopical, laboratory and histopathological findings.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • •patient refusal to participate

Outcomes

Primary Outcomes

Change of microbiome in chronic inflammatory bowel disease

Time Frame: 5 yrs

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other Gov
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
Correlation Between Intestinal Microbiota, Inflamatory Biomarkers, Intestinal Morphology, Hepatic Fibrosis Degree and Vascular Reactivity.Microbial Colonization
NCT03178006Rio de Janeiro State University46
Recruiting
Not Applicable
The role of gut microbiota and chronic inflammation as drivers of cardiovascular disease - Nijmegen Biomedical Study - Non Invasive markers of Atherosclerosis 3atherosclerosiscardiovascular disease
NL-OMON38378niversitair Medisch Centrum Sint Radboud500
Completed
Not Applicable
Gastrointestinal Microbiome Influence on the Development of Bronchopulmonary DysplasiaBronchopulmonary Dysplasia
NCT03229967University of Tennessee197
Completed
Not Applicable
The role of the intestinal microbiome in enteric and systemic vaccine immune responsesvaccin immunogeniciteitimmunityrotavirus vaccine1001796610047438
NL-OMON44814Academisch Medisch Centrum63
Unknown
Not Applicable
The Role of Gut Microbiome and Chronic Inflammation in Young-onset Colorectal CancerColorectal Cancer
NCT04011969Fakultas Kedokteran Universitas Indonesia150